RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Qianzhan Investment Management
Q

Qianzhan Investment Management portfolio

Qianzhan Investment Management has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $204M.
Latest deal: Immune-Onc Therapeutics · Jan 5, 2023.
About this page

Its most recent investment on record is Immune-Onc Therapeutics's $131M Series B+ round in January 2023, alongside BOCOM International, TriWise Capital and Proxima Ventures Ltd. That company is in Health and bio. It has co-invested with BOCOM International, TriWise Capital and Proxima Ventures Ltd.

What Qianzhan Investment Management invests in

How Qianzhan Investment Management invests

StageDealsCapital in rounds
Series B+ 2 100%$204M
YearDealsCapital in rounds
2021 1 50%$73M
2023 1 50%$131M

Qianzhan Investment Management portfolio companies

CompanyRound with Qianzhan Investment ManagementTotal raisedLatest raise
IImmune-Onc Therapeutics
Health and bio
Series B+ · $131M$211MJan 5, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Qianzhan Investment Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Qianzhan Investment Management, which is a subset of its real portfolio. API: /api/v1/investors/qianzhan-investment-management (get a free API key). More: the most active VC firms and new venture capital funds.